Abstract 2709: Modulation of the tumor-infiltrating lymphocyte population by PARP inhibitor talazoparib in combination with anti-PD1 treatment significantly enhances overall survival in a murine BRCA1-/-breast cancer model
2019 ◽
2013 ◽
Vol 87
(2)
◽
pp. S649
Keyword(s):
2004 ◽
Vol 121
(2)
◽
pp. 280
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 12
(11)
◽
pp. 2389-2399
◽
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 38
(1)
◽
pp. 1099-1110
Keyword(s):